Metabolic Capability of <i>Penicillium oxalicum</i> to Transform High Concentrations of Anti-Inflammatory and Analgesic Drugs

• Main Authors: Darío Rafael Olicón-Hernández, Maite Ortúzar, Clementina Pozo, Jesús González-López, Elisabet Aranda
• Format: Article
• Language: English
• Published: MDPI AG 2020-04-01
• Series: Applied Sciences
• Subjects: ascomycetes; analgesics; emerging contaminants; biodegradation; non-steroidal anti-inflammatory drugs; <i>Penicillium oxalicum</i>
• Online Access: https://www.mdpi.com/2076-3417/10/7/2479

Non-steroidal anti-inflammatory drugs (NSAIDs) and analgesics are two of the most employed drug groups around the world due to their use in the treatment of edema and pain. However, they also present an ecological challenge because they are considered as potential water pollutants. In this work, the biodegradation of four NSAIDs (diclofenac, ibuprofen, naproxen and ketoprofen) and one analgesic (acetaminophen) at 50 µM (initial concentration) by <i>Penicillium oxalicum</i>, at both flask and bioreactor bench scales, was evaluated. An important co-metabolic mechanism as part of the global bioremediation process for the elimination of these drugs was observed, as in some cases it was necessary to supplement glucose to achieve a 100% removal rate: both individually and as a complex mixture. Identical behavior in the implementation of a fluidized bench-scale batch bioreactor, inoculated with pellets of this fungus and the complex mix of the drugs, was observed. The role of the cytochrome P450 enzymes (CYP) in the biodegradation of the drugs mix were evidenced by the observation of hydroxylated by-products. The results on the reduction of toxicity (micro and phyto) were not conclusive; however, a reduction in phytotoxicity was detected.